As of Feb 05
| -0.24 / -4.81%|
The 4 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 15.50, with a high estimate of 21.00 and a low estimate of 10.00. The median estimate represents a +226.32% increase from the last price of 4.75.
The current consensus among 8 polled investment analysts is to Hold stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.